Metropolitan General Hospital

Research site

Greece Messogeion 264, 15562 Athens, Greece

Hormone-refractory prostate cancer · Prostate cancer metastatic · Prostate cancer
Adult patients

About Specializations

Metropolitan General Hospital in Athens, Greece specialises in clinical trials of conditions such as Hormone-refractory prostate cancer, Prostate cancer metastatic, Prostate cancer, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Messogeion 26415562 AthensGreece

Open in maps ↗

Recruiting now: no trials
Conditions studied: 3

More sites in Athens Greece

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Quick filters

1 clinical trial

Hormone-refractory prostate cancer+2

Not recruiting

Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

Registered drug

Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

Registered drug

Greece

Participants:18–64 years · 65+ years
Substances:Capivasertib
Sponsor:AstraZeneca AB

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites